Impact of Risk Stacking on COVID-19–Related Healthcare Utilization: A Real-World Retrospective Cohort Study
Younger adults with multiple non-immunocompromising comorbidities had greater risk of COVID-19-related HCRU than those with immunocompromising conditions or ≥ 65 years without multimorbidity. Stacking HR comorbidities increased the risk of HCRU. Ensuring broad vaccination and treatment recommendations and access is critical to mitigating severe COVID-19 in HR groups of any age.
Authors
- Laura Puzniak (ORCID: https://orcid.org/0000-0001-8697-9683)
- Maya Reimbaeva (ORCID: https://orcid.org/0000-0002-1823-8995)
- Daniel Curcio (ORCID: https://orcid.org/0000-0002-3387-2433)
- Santiago M. C. Lopez (ORCID: https://orcid.org/0000-0001-7714-1707)
- Laura Choi
- Leah J. McGrath (ORCID: https://orcid.org/0000-0002-0312-635X)
- Luis Jódar (ORCID: https://orcid.org/0000-0003-1246-530X)
- Alejandro Cané (ORCID: https://orcid.org/0000-0003-0778-6862)
- Frank R. Ernst (ORCID: https://orcid.org/0000-0001-6927-9765)
- Lili Jiang (ORCID: https://orcid.org/0000-0002-7628-237X)
- Mary M. Moran
- Irini Zografaki
Institutions
- Pfizer (United States) (US)
- Pfizer (Spain) (ES)
- Pfizer (Canada) (CA)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-12-05
- DOI
- https://doi.org/10.1007/s40121-025-01259-3
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00